CompletedNot Applicable

Double Crossover Casein Type Tolerance Trial

United States48 participantsStarted 2024-04-20

Plain-language summary

The investigators will recruit 45 fluid milk avoiding adults to participate in a five-week double-blind, double-crossover study in which the physiological responses to increasing doses of lactose-free (A1-rich milk), A2 milk, and lactose-free A2 milk will be explored.

Who can participate

Age range18 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults age 18+ * Currently avoid liquid milk * Can read and speak English Exclusion Criteria: * Diagnosis of milk protein allergy * Diagnosis of Crohn's Disease, Ulcerative Colitis, Celiac Disease, or Peptic Ulcer Disease or Gastroparesis * Using antibiotic or antiviral medications within 30 days prior to study start * Undergoing chemotherapy, or using any investigational drugs within 30 days prior to study start * Pregnant or lactating

What they're measuring

Gastrointestinal Distress Scores

Timeframe: 24 hours after each sample challenge

Trial details

NCT IDNCT06315517

SponsorAuburn University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-07-26

View on ClinicalTrials.gov More Dairy Intolerance trials